Showing results (141-150 of 269) with videos related to
Sort By:
Pageof 27
Annals of Hematology|May 28, 2026
Daratumumab in combination with GDP chemotherapy in CD38-positive relapsed/refractory peripheral T-cell lymphoma: a phase 2 study of the Fondazione Italiana LinfomiMario Ballerini, Elisa Lucchini, Emanuele Ravano, et al.Oncoimmunology|April 14, 2017
NK cells control breast cancer and related cancer stem cell hematological spreadRossana Tallerico, Laura Conti, Stefania Lanzardo, et al.Frontiers in Immunology|July 24, 2023
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung diseaseSeok-Chan Park, Laura Conti, Valentina Franceschi, et al.Cancers|March 6, 2021
Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast CancerRoberto Ruiu, Giuseppina Barutello, Maddalena Arigoni, et al.Cancer Immunology, Immunotherapy : CII|February 4, 2005
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenarioAnnalisa Astolfi, Simona Rolla, Patrizia Nanni, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2010
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacySimona Rolla, Francesco Ria, Sergio Occhipinti, et al.Frontiers in Immunology|March 31, 2025
OligoDOMTM: a T-cell response-enhancing platform applied to cancer immunotherapyJudith Del Campo, Séverine Valsesia, Elsa Nikly, et al.International Journal of Nanomedicine|March 5, 2026
Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor MicroenvironmentAntonino Di Lorenzo, Chiara Romiti, Alessandro Amaolo, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2014
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male miceMarco Macagno, Silvio Bandini, Lorenzo Stramucci, et al.Cancer Research|March 25, 2010
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteinsElena Quaglino, Cristina Mastini, Augusto Amici, et al.Pageof 27